

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.35101134 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.57580842 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.57057934 |
| 4 | respiratory burst (GO:0045730) | 4.75958784 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.71223619 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.71223619 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.71223619 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.71223619 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.71223619 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.71223619 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.51101703 |
| 12 | neutrophil mediated immunity (GO:0002446) | 4.44013331 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.43952034 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.43335040 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34998886 |
| 16 | neutrophil activation (GO:0042119) | 4.27855121 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20440676 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.16821425 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.15155203 |
| 20 | B cell receptor signaling pathway (GO:0050853) | 4.11954368 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 4.08482886 |
| 22 | response to peptidoglycan (GO:0032494) | 4.06618156 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03625317 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.03625317 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 4.03521608 |
| 26 | granulocyte activation (GO:0036230) | 4.03000161 |
| 27 | regulation of platelet aggregation (GO:0090330) | 3.89251467 |
| 28 | cellular extravasation (GO:0045123) | 3.88666699 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.86152385 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.84832115 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.83418328 |
| 32 | regulation of platelet activation (GO:0010543) | 3.81867232 |
| 33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.74936791 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73509715 |
| 35 | pinocytosis (GO:0006907) | 3.72445132 |
| 36 | regulation of mast cell activation (GO:0033003) | 3.70273589 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.70164113 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.66418098 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.61688198 |
| 40 | mast cell activation (GO:0045576) | 3.61339298 |
| 41 | cellular response to zinc ion (GO:0071294) | 3.59509594 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.54851418 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.53090608 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.50271418 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49576365 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49576365 |
| 47 | detection of other organism (GO:0098543) | 3.46245440 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45914237 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.45349165 |
| 50 | positive regulation of interferon-alpha production (GO:0032727) | 3.43843827 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.39038753 |
| 52 | leukocyte aggregation (GO:0070486) | 3.38927916 |
| 53 | defense response to protozoan (GO:0042832) | 3.36032918 |
| 54 | leukocyte mediated cytotoxicity (GO:0001909) | 3.34438671 |
| 55 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.31484181 |
| 56 | adenosine receptor signaling pathway (GO:0001973) | 3.31226058 |
| 57 | microglial cell activation (GO:0001774) | 3.31088486 |
| 58 | superoxide anion generation (GO:0042554) | 3.30698825 |
| 59 | response to fungus (GO:0009620) | 3.29524862 |
| 60 | B cell mediated immunity (GO:0019724) | 3.27851919 |
| 61 | myeloid dendritic cell activation (GO:0001773) | 3.27625419 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.26978163 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 3.26978163 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.25779639 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25505433 |
| 66 | response to host immune response (GO:0052572) | 3.25505433 |
| 67 | thrombin receptor signaling pathway (GO:0070493) | 3.24387718 |
| 68 | regulation of interferon-alpha production (GO:0032647) | 3.23779967 |
| 69 | macrophage activation (GO:0042116) | 3.21748223 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 3.21337157 |
| 71 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.21017576 |
| 72 | germinal center formation (GO:0002467) | 3.19640008 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.18614050 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15698960 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15698960 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.15499885 |
| 77 | response to protozoan (GO:0001562) | 3.14716296 |
| 78 | T cell migration (GO:0072678) | 3.12530473 |
| 79 | protein neddylation (GO:0045116) | 3.12292760 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.11758901 |
| 81 | myeloid leukocyte activation (GO:0002274) | 3.10514937 |
| 82 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.10485696 |
| 83 | reactive oxygen species biosynthetic process (GO:1903409) | 3.10117176 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07226218 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.07173642 |
| 86 | detection of bacterium (GO:0016045) | 3.05909174 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97266534 |
| 88 | interferon-gamma production (GO:0032609) | 2.94735221 |
| 89 | dendritic cell migration (GO:0036336) | 2.93838073 |
| 90 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93578049 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93436212 |
| 92 | response to host (GO:0075136) | 2.93436212 |
| 93 | response to host defenses (GO:0052200) | 2.93436212 |
| 94 | leukocyte degranulation (GO:0043299) | 2.92959010 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.91250821 |
| 96 | leukotriene metabolic process (GO:0006691) | 2.90285318 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 2.89620601 |
| 98 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.89470066 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89222097 |
| 100 | negative regulation of mast cell activation (GO:0033004) | 2.88718386 |
| 101 | B cell homeostasis (GO:0001782) | 2.86211313 |
| 102 | B cell proliferation (GO:0042100) | 2.85596942 |
| 103 | positive regulation of macrophage differentiation (GO:0045651) | 2.84863656 |
| 104 | dendritic cell chemotaxis (GO:0002407) | 2.84395483 |
| 105 | negative regulation of growth of symbiont in host (GO:0044130) | 2.83775111 |
| 106 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.83775111 |
| 107 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.83775111 |
| 108 | regulation of growth of symbiont in host (GO:0044126) | 2.83775111 |
| 109 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.83461183 |
| 110 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.82781016 |
| 111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81617868 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80285800 |
| 113 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80019544 |
| 114 | cellular response to exogenous dsRNA (GO:0071360) | 2.79467065 |
| 115 | cellular response to interferon-beta (GO:0035458) | 2.78404266 |
| 116 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75724582 |
| 117 | negative regulation of B cell proliferation (GO:0030889) | 2.75595384 |
| 118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.74661539 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.74014307 |
| 120 | actin nucleation (GO:0045010) | 2.72866450 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.72043413 |
| 122 | phagocytosis, engulfment (GO:0006911) | 2.71900263 |
| 123 | cytidine metabolic process (GO:0046087) | 2.68562151 |
| 124 | cytidine catabolic process (GO:0006216) | 2.68562151 |
| 125 | cytidine deamination (GO:0009972) | 2.68562151 |
| 126 | neutrophil chemotaxis (GO:0030593) | 2.68339105 |
| 127 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.67701770 |
| 128 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.67428260 |
| 129 | regulation of interleukin-17 production (GO:0032660) | 2.65841497 |
| 130 | negative regulation of platelet activation (GO:0010544) | 2.65833027 |
| 131 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64877533 |
| 132 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.64674516 |
| 133 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63978709 |
| 134 | lipoxygenase pathway (GO:0019372) | 2.61547765 |
| 135 | neutrophil migration (GO:1990266) | 2.61202706 |
| 136 | positive regulation of leukocyte degranulation (GO:0043302) | 2.59244656 |
| 137 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.57949067 |
| 138 | histamine secretion (GO:0001821) | 2.57603944 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.57043162 |
| 140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56133686 |
| 141 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.52733832 |
| 142 | positive regulation of type 2 immune response (GO:0002830) | 2.52011122 |
| 143 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.51428453 |
| 144 | positive regulation of macrophage cytokine production (GO:0060907) | 2.49868151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.05030869 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.39355713 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37445564 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.42372167 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.07657274 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.99918108 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.91575751 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.74402634 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71590067 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.49026373 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37454538 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37083270 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.24457722 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.09081692 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87721023 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.83552314 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68908231 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67034099 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.55902499 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52964501 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.48067120 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45060222 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.44468412 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.43240310 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.39707823 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38677397 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31391608 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.28510392 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.22946305 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.21404198 |
| 31 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18846403 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.12229229 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10075288 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04919908 |
| 35 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01157288 |
| 36 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00178340 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99397143 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96566157 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94919354 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87864726 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.87035472 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84186263 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.81314294 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.81058786 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75821755 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75413665 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73540328 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71639599 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.70258002 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69523653 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62567183 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60361393 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58126414 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56533221 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54937609 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54411009 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.53554594 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.53420768 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52964646 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47604986 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.45738261 |
| 62 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43485198 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43012358 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42529952 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40446021 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37432172 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.36889879 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36287811 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36055675 |
| 70 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.34538050 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32553040 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31417720 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30813143 |
| 74 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30358330 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28266713 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26762571 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25854636 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23930997 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22739319 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22545685 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19559806 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18940788 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18032018 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15741501 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15106210 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14351701 |
| 87 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.10012521 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09991122 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06076079 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06076079 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.04917062 |
| 92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04059440 |
| 93 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02695336 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02210767 |
| 95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99318810 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95667243 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 0.95464150 |
| 98 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95391604 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95208464 |
| 100 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.93972902 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92532911 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90999299 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90668913 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88274524 |
| 105 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86400895 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86370904 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.86255139 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85977507 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85886309 |
| 110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84768691 |
| 111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84532403 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83485819 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82476147 |
| 114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82003308 |
| 115 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81810724 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81421995 |
| 117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80586723 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80177424 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79991836 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79716956 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79448672 |
| 122 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79437386 |
| 123 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78972632 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.76998119 |
| 125 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76998119 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75741637 |
| 127 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75715300 |
| 128 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.75583854 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75143503 |
| 130 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74235338 |
| 131 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.72840663 |
| 132 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.71374955 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70730442 |
| 134 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.68787806 |
| 135 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66727034 |
| 136 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.65373944 |
| 137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.65334782 |
| 138 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.64802289 |
| 139 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.61184963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.67777077 |
| 2 | MP0003436_decreased_susceptibility_to | 3.54573866 |
| 3 | MP0002419_abnormal_innate_immunity | 3.21191076 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.19939026 |
| 5 | MP0003303_peritoneal_inflammation | 3.11405424 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.08482887 |
| 7 | MP0009785_altered_susceptibility_to | 2.96271599 |
| 8 | MP0005671_abnormal_response_to | 2.90901168 |
| 9 | MP0001800_abnormal_humoral_immune | 2.86512543 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.82985197 |
| 11 | MP0005025_abnormal_response_to | 2.79911479 |
| 12 | MP0005387_immune_system_phenotype | 2.65303234 |
| 13 | MP0001790_abnormal_immune_system | 2.65303234 |
| 14 | MP0002723_abnormal_immune_serum | 2.61493678 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.60494247 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.60367458 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.57864647 |
| 18 | MP0001819_abnormal_immune_cell | 2.57785748 |
| 19 | MP0000685_abnormal_immune_system | 2.50426928 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.37592385 |
| 21 | MP0003724_increased_susceptibility_to | 2.35780520 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.31974803 |
| 23 | MP0008004_abnormal_stomach_pH | 2.28165073 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.25389410 |
| 25 | MP0006082_CNS_inflammation | 2.23688840 |
| 26 | MP0002405_respiratory_system_inflammati | 2.15302388 |
| 27 | MP0002398_abnormal_bone_marrow | 2.11438553 |
| 28 | MP0000716_abnormal_immune_system | 2.02024720 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.96105309 |
| 30 | MP0001853_heart_inflammation | 1.92951001 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.90873377 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.87866218 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.86046288 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.85110407 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.83724272 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.80330668 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.80233228 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.74752422 |
| 39 | MP0002429_abnormal_blood_cell | 1.70667773 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.70398075 |
| 41 | MP0002722_abnormal_immune_system | 1.67122130 |
| 42 | MP0000343_altered_response_to | 1.62732104 |
| 43 | MP0002006_tumorigenesis | 1.62456399 |
| 44 | MP0009278_abnormal_bone_marrow | 1.62157431 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.61180038 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.61180038 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.60338760 |
| 48 | MP0004510_myositis | 1.60125385 |
| 49 | MP0004130_abnormal_muscle_cell | 1.59964946 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.59320627 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.57379376 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.56159408 |
| 53 | MP0003879_abnormal_hair_cell | 1.54746421 |
| 54 | MP0004036_abnormal_muscle_relaxation | 1.52343170 |
| 55 | MP0008469_abnormal_protein_level | 1.42802754 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.39835085 |
| 57 | MP0001873_stomach_inflammation | 1.39770431 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.38017456 |
| 59 | MP0000858_altered_metastatic_potential | 1.35498169 |
| 60 | MP0003448_altered_tumor_morphology | 1.30187378 |
| 61 | MP0000490_abnormal_crypts_of | 1.25333928 |
| 62 | MP0003828_pulmonary_edema | 1.24520721 |
| 63 | MP0004947_skin_inflammation | 1.22461104 |
| 64 | MP0004484_altered_response_of | 1.20429122 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.19744689 |
| 66 | MP0003075_altered_response_to | 1.19346712 |
| 67 | MP0005310_abnormal_salivary_gland | 1.16003160 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.14274454 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.13056408 |
| 70 | MP0003646_muscle_fatigue | 1.12728999 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.12683215 |
| 72 | MP0008874_decreased_physiological_sensi | 1.12439638 |
| 73 | MP0001851_eye_inflammation | 1.10649499 |
| 74 | MP0009764_decreased_sensitivity_to | 1.09707811 |
| 75 | MP0003866_abnormal_defecation | 1.06807467 |
| 76 | MP0000604_amyloidosis | 1.06117028 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.06036296 |
| 78 | MP0000371_diluted_coat_color | 1.01085381 |
| 79 | MP0005166_decreased_susceptibility_to | 0.98547928 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.98334543 |
| 81 | MP0010307_abnormal_tumor_latency | 0.98328795 |
| 82 | MP0002933_joint_inflammation | 0.96869453 |
| 83 | MP0004742_abnormal_vestibular_system | 0.95981088 |
| 84 | MP0003690_abnormal_glial_cell | 0.94420722 |
| 85 | MP0005620_abnormal_muscle_contractility | 0.90262621 |
| 86 | MP0005451_abnormal_body_composition | 0.90217578 |
| 87 | MP0000920_abnormal_myelination | 0.88812594 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.86817992 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.86129142 |
| 90 | MP0000249_abnormal_blood_vessel | 0.83340420 |
| 91 | MP0002972_abnormal_cardiac_muscle | 0.82643234 |
| 92 | MP0009046_muscle_twitch | 0.82156354 |
| 93 | MP0005409_darkened_coat_color | 0.81900011 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.80940562 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.80284351 |
| 96 | MP0003045_fibrosis | 0.79940339 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.77606577 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.76308412 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.76068372 |
| 100 | MP0009763_increased_sensitivity_to | 0.75480558 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.73849756 |
| 102 | MP0010094_abnormal_chromosome_stability | 0.73709296 |
| 103 | MP0001663_abnormal_digestive_system | 0.73608723 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.73376648 |
| 105 | MP0002736_abnormal_nociception_after | 0.72528374 |
| 106 | MP0008057_abnormal_DNA_replication | 0.72217925 |
| 107 | MP0003880_abnormal_central_pattern | 0.71251074 |
| 108 | MP0004381_abnormal_hair_follicle | 0.70545057 |
| 109 | MP0009840_abnormal_foam_cell | 0.70071278 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.69930441 |
| 111 | MP0005390_skeleton_phenotype | 0.69818187 |
| 112 | MP0008569_lethality_at_weaning | 0.68750224 |
| 113 | MP0005535_abnormal_body_temperature | 0.68133766 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.65078520 |
| 115 | MP0005164_abnormal_response_to | 0.64324768 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.64226166 |
| 117 | MP0003633_abnormal_nervous_system | 0.64178524 |
| 118 | MP0001970_abnormal_pain_threshold | 0.63782387 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.63692233 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.63573805 |
| 121 | MP0002277_abnormal_respiratory_mucosa | 0.62589328 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.62201613 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.58751577 |
| 124 | MP0002132_abnormal_respiratory_system | 0.58751514 |
| 125 | MP0003279_aneurysm | 0.57873699 |
| 126 | MP0000372_irregular_coat_pigmentation | 0.57549502 |
| 127 | MP0001879_abnormal_lymphatic_vessel | 0.57249077 |
| 128 | MP0003795_abnormal_bone_structure | 0.56613748 |
| 129 | MP0001915_intracranial_hemorrhage | 0.56459391 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.56417217 |
| 131 | MP0004883_abnormal_blood_vessel | 0.55065602 |
| 132 | MP0001186_pigmentation_phenotype | 0.54523748 |
| 133 | MP0008260_abnormal_autophagy | 0.54485174 |
| 134 | MP0008873_increased_physiological_sensi | 0.53908913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.30960855 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.51953941 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.12503176 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.75222057 |
| 5 | Purpura (HP:0000979) | 4.70023383 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.55113533 |
| 7 | Myositis (HP:0100614) | 4.55077368 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.54159069 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.44363324 |
| 10 | Obstructive lung disease (HP:0006536) | 4.44363324 |
| 11 | Abnormal platelet volume (HP:0011876) | 4.39849733 |
| 12 | Recurrent skin infections (HP:0001581) | 4.22515750 |
| 13 | Increased mean platelet volume (HP:0011877) | 4.22321995 |
| 14 | Menorrhagia (HP:0000132) | 4.20466681 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.14462641 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.04299221 |
| 17 | Meningitis (HP:0001287) | 3.80435932 |
| 18 | Recurrent viral infections (HP:0004429) | 3.67592323 |
| 19 | IgM deficiency (HP:0002850) | 3.63208681 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.56902915 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.50826823 |
| 22 | Gingivitis (HP:0000230) | 3.45321245 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.43814920 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.43814920 |
| 25 | Orchitis (HP:0100796) | 3.32589227 |
| 26 | Nemaline bodies (HP:0003798) | 3.31774089 |
| 27 | Cellulitis (HP:0100658) | 3.27945942 |
| 28 | Muscle fiber inclusion bodies (HP:0100299) | 3.24195991 |
| 29 | Vasculitis (HP:0002633) | 3.22579106 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.18304152 |
| 31 | Optic neuritis (HP:0100653) | 3.18304152 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.10865602 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.10506682 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.09713256 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.09713256 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.09713256 |
| 37 | Thrombocytosis (HP:0001894) | 3.06367415 |
| 38 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.06330089 |
| 39 | Agnosia (HP:0010524) | 3.05630907 |
| 40 | Abnormality of the prostate (HP:0008775) | 3.04906177 |
| 41 | Muscle fiber splitting (HP:0003555) | 3.01549733 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.00151837 |
| 43 | Stomatitis (HP:0010280) | 2.95050118 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94381704 |
| 45 | Prostate neoplasm (HP:0100787) | 2.91362348 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.88718675 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.88659330 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87816201 |
| 49 | Periodontitis (HP:0000704) | 2.84609086 |
| 50 | Conjunctival telangiectasia (HP:0000524) | 2.82940199 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.81632162 |
| 52 | Colitis (HP:0002583) | 2.78527386 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.78378105 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.77932616 |
| 55 | Pustule (HP:0200039) | 2.75798380 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.74950690 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.74611383 |
| 58 | Disinhibition (HP:0000734) | 2.74288895 |
| 59 | Chronic otitis media (HP:0000389) | 2.73048022 |
| 60 | Petechiae (HP:0000967) | 2.72328270 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.71795675 |
| 62 | Atonic seizures (HP:0010819) | 2.70639648 |
| 63 | Osteomyelitis (HP:0002754) | 2.67822818 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.61440411 |
| 65 | Hematochezia (HP:0002573) | 2.60485746 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.60112432 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.56129115 |
| 68 | Glomerulonephritis (HP:0000099) | 2.54136767 |
| 69 | Hemoptysis (HP:0002105) | 2.53894955 |
| 70 | Febrile seizures (HP:0002373) | 2.51633625 |
| 71 | Mutism (HP:0002300) | 2.50804281 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.49435087 |
| 73 | Leukocytosis (HP:0001974) | 2.48884684 |
| 74 | Paralysis (HP:0003470) | 2.46962677 |
| 75 | Eosinophilia (HP:0001880) | 2.46819743 |
| 76 | Lymphopenia (HP:0001888) | 2.44889817 |
| 77 | Epistaxis (HP:0000421) | 2.43441095 |
| 78 | Vertigo (HP:0002321) | 2.40211195 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.38393043 |
| 80 | Thyroiditis (HP:0100646) | 2.36864805 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36398818 |
| 82 | Abnormality of T cells (HP:0002843) | 2.35866117 |
| 83 | Episodic fever (HP:0001954) | 2.34144619 |
| 84 | Axonal loss (HP:0003447) | 2.33893889 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31958583 |
| 86 | Encephalitis (HP:0002383) | 2.28254499 |
| 87 | Increased IgM level (HP:0003496) | 2.28132927 |
| 88 | Keratoconjunctivitis (HP:0001096) | 2.27944677 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 2.26867155 |
| 90 | Urticaria (HP:0001025) | 2.26280323 |
| 91 | T lymphocytopenia (HP:0005403) | 2.25741580 |
| 92 | Pulmonary embolism (HP:0002204) | 2.25317381 |
| 93 | Abnormal platelet function (HP:0011869) | 2.25060086 |
| 94 | Impaired platelet aggregation (HP:0003540) | 2.25060086 |
| 95 | Arterial thrombosis (HP:0004420) | 2.24480291 |
| 96 | Abnormality of lateral ventricle (HP:0030047) | 2.24037065 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 2.22685851 |
| 98 | Abnormality of T cell number (HP:0011839) | 2.21569320 |
| 99 | Recurrent bronchitis (HP:0002837) | 2.21010768 |
| 100 | Granulocytopenia (HP:0001913) | 2.19813418 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.19685465 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19685465 |
| 103 | Chest pain (HP:0100749) | 2.18845124 |
| 104 | Thoracic kyphosis (HP:0002942) | 2.18266578 |
| 105 | Diplopia (HP:0000651) | 2.18257414 |
| 106 | Abnormality of binocular vision (HP:0011514) | 2.18257414 |
| 107 | Restrictive lung disease (HP:0002091) | 2.16759969 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.15474593 |
| 109 | Keratoconjunctivitis sicca (HP:0001097) | 2.15245525 |
| 110 | Myocardial infarction (HP:0001658) | 2.15030356 |
| 111 | Sepsis (HP:0100806) | 2.14658691 |
| 112 | J-shaped sella turcica (HP:0002680) | 2.12361533 |
| 113 | Gingival bleeding (HP:0000225) | 2.11557818 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10909871 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10909871 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10909871 |
| 117 | Lymphoma (HP:0002665) | 2.09538117 |
| 118 | Joint hemorrhage (HP:0005261) | 2.09460815 |
| 119 | Abnormality of B cell number (HP:0010975) | 2.08763851 |
| 120 | B lymphocytopenia (HP:0010976) | 2.08763851 |
| 121 | Increased serum ferritin (HP:0003281) | 2.08529697 |
| 122 | Joint swelling (HP:0001386) | 2.06263313 |
| 123 | Hemiplegia (HP:0002301) | 2.06117634 |
| 124 | Exercise-induced myalgia (HP:0003738) | 2.04739562 |
| 125 | Albinism (HP:0001022) | 2.04073280 |
| 126 | Hepatosplenomegaly (HP:0001433) | 2.02851504 |
| 127 | Ventricular fibrillation (HP:0001663) | 2.02263432 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 2.01895260 |
| 129 | Abnormality of eosinophils (HP:0001879) | 2.01133539 |
| 130 | Difficulty running (HP:0009046) | 1.99961862 |
| 131 | Skin ulcer (HP:0200042) | 1.99870836 |
| 132 | Polycythemia (HP:0001901) | 1.98803150 |
| 133 | Chronic diarrhea (HP:0002028) | 1.98192406 |
| 134 | Loss of speech (HP:0002371) | 1.89313355 |
| 135 | Polyneuropathy (HP:0001271) | 1.84582883 |
| 136 | Bruising susceptibility (HP:0000978) | 1.83827856 |
| 137 | Frequent falls (HP:0002359) | 1.82336908 |
| 138 | Memory impairment (HP:0002354) | 1.79045995 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79043533 |
| 140 | Gangrene (HP:0100758) | 1.76668133 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.75912210 |
| 142 | Distal arthrogryposis (HP:0005684) | 1.75498077 |
| 143 | Cerebral hemorrhage (HP:0001342) | 1.73594249 |
| 144 | Round ear (HP:0100830) | 1.73160352 |
| 145 | Exercise-induced muscle cramps (HP:0003710) | 1.72882596 |
| 146 | Anorexia (HP:0002039) | 1.72275358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.87584940 |
| 2 | IRAK4 | 3.79313376 |
| 3 | BLK | 3.66369264 |
| 4 | RIPK4 | 3.45325388 |
| 5 | KIT | 2.92255692 |
| 6 | MAP3K14 | 2.84859047 |
| 7 | TYK2 | 2.50246612 |
| 8 | IRAK3 | 2.45493688 |
| 9 | TEC | 2.45218843 |
| 10 | TGFBR2 | 2.32376168 |
| 11 | TXK | 2.24428649 |
| 12 | BTK | 2.24097884 |
| 13 | OBSCN | 2.19439083 |
| 14 | CSF1R | 2.13370376 |
| 15 | TBK1 | 1.99577345 |
| 16 | CLK1 | 1.96579751 |
| 17 | MAP2K3 | 1.88281536 |
| 18 | SYK | 1.80846542 |
| 19 | FES | 1.78075757 |
| 20 | ZAP70 | 1.73653664 |
| 21 | TAOK3 | 1.65206326 |
| 22 | TAOK1 | 1.60360538 |
| 23 | JAK1 | 1.57667430 |
| 24 | ITK | 1.54867196 |
| 25 | CSK | 1.52816648 |
| 26 | HCK | 1.50055709 |
| 27 | IKBKB | 1.46970403 |
| 28 | PIM2 | 1.46299212 |
| 29 | JAK3 | 1.46217071 |
| 30 | IKBKE | 1.45444767 |
| 31 | LYN | 1.44431751 |
| 32 | STK10 | 1.36051832 |
| 33 | GRK7 | 1.35221445 |
| 34 | LCK | 1.34437415 |
| 35 | MAP3K13 | 1.31046376 |
| 36 | GRK5 | 1.30563938 |
| 37 | TNIK | 1.28369293 |
| 38 | MATK | 1.23598524 |
| 39 | YES1 | 1.21286068 |
| 40 | PTK2B | 1.17460302 |
| 41 | MAP3K11 | 1.17018098 |
| 42 | BMX | 1.11732056 |
| 43 | IRAK1 | 1.11557276 |
| 44 | ERN1 | 1.10360159 |
| 45 | PIM1 | 1.09982499 |
| 46 | TRPM7 | 1.08827953 |
| 47 | MST4 | 1.08811054 |
| 48 | DAPK2 | 1.06767943 |
| 49 | SIK2 | 1.05266524 |
| 50 | SIK3 | 1.02099189 |
| 51 | MAP3K3 | 1.01920295 |
| 52 | RPS6KA4 | 1.01839531 |
| 53 | MYLK | 1.01433156 |
| 54 | NEK9 | 1.01346156 |
| 55 | EPHA3 | 1.00058965 |
| 56 | ADRBK2 | 0.99736144 |
| 57 | FLT3 | 0.91557536 |
| 58 | NME2 | 0.87354520 |
| 59 | MAP3K1 | 0.84225844 |
| 60 | IRAK2 | 0.83105385 |
| 61 | GRK6 | 0.82132923 |
| 62 | KDR | 0.81865673 |
| 63 | PINK1 | 0.80481018 |
| 64 | TRIM28 | 0.79348964 |
| 65 | EIF2AK2 | 0.78227728 |
| 66 | STK4 | 0.77748829 |
| 67 | FYN | 0.77321482 |
| 68 | MAP3K5 | 0.76243797 |
| 69 | MAP3K12 | 0.76114004 |
| 70 | VRK1 | 0.75656121 |
| 71 | JAK2 | 0.74599609 |
| 72 | PHKG1 | 0.73761753 |
| 73 | PHKG2 | 0.73761753 |
| 74 | TNK2 | 0.68945295 |
| 75 | TTN | 0.67624811 |
| 76 | TIE1 | 0.66344690 |
| 77 | MAP3K6 | 0.65651327 |
| 78 | EIF2AK3 | 0.65649250 |
| 79 | LRRK2 | 0.65529832 |
| 80 | FGFR3 | 0.65095740 |
| 81 | PRKG1 | 0.64335835 |
| 82 | CAMKK2 | 0.64155349 |
| 83 | SGK2 | 0.63790285 |
| 84 | RPS6KA6 | 0.63626999 |
| 85 | FRK | 0.62839059 |
| 86 | CDK6 | 0.62252070 |
| 87 | MAP2K4 | 0.62108370 |
| 88 | CHUK | 0.61577920 |
| 89 | MAP2K6 | 0.61074668 |
| 90 | MAPK4 | 0.59950286 |
| 91 | RET | 0.58956964 |
| 92 | EEF2K | 0.58076304 |
| 93 | MAP3K10 | 0.57804716 |
| 94 | NTRK3 | 0.57183709 |
| 95 | KSR1 | 0.56585441 |
| 96 | KSR2 | 0.55620174 |
| 97 | CAMK1D | 0.54778518 |
| 98 | TAOK2 | 0.54301081 |
| 99 | PIK3CG | 0.53512643 |
| 100 | RPS6KC1 | 0.52763928 |
| 101 | RPS6KL1 | 0.52763928 |
| 102 | SGK3 | 0.52273148 |
| 103 | STK24 | 0.51687091 |
| 104 | SCYL2 | 0.51530328 |
| 105 | ABL1 | 0.50914581 |
| 106 | PRKCD | 0.50857557 |
| 107 | CDC7 | 0.50506258 |
| 108 | PAK4 | 0.49871315 |
| 109 | MAPK13 | 0.48943698 |
| 110 | PDPK1 | 0.48475800 |
| 111 | FER | 0.46651347 |
| 112 | MARK2 | 0.46497778 |
| 113 | MAPKAPK2 | 0.46059139 |
| 114 | PRKD1 | 0.45670765 |
| 115 | STK16 | 0.45278632 |
| 116 | EPHB1 | 0.42744161 |
| 117 | PKN1 | 0.42679357 |
| 118 | ATR | 0.42462278 |
| 119 | PLK2 | 0.41118567 |
| 120 | MARK3 | 0.40697002 |
| 121 | ACVR1B | 0.40554419 |
| 122 | BMPR2 | 0.40197811 |
| 123 | BMPR1B | 0.39992057 |
| 124 | EGFR | 0.39903061 |
| 125 | CDK4 | 0.38708060 |
| 126 | PDK1 | 0.38208676 |
| 127 | NLK | 0.38142456 |
| 128 | CAMK2A | 0.37480223 |
| 129 | MOS | 0.36083760 |
| 130 | MAPK12 | 0.35518876 |
| 131 | PRKACG | 0.35420490 |
| 132 | ILK | 0.35416151 |
| 133 | MINK1 | 0.32615475 |
| 134 | TESK2 | 0.32508538 |
| 135 | FGR | 0.32321205 |
| 136 | CCNB1 | 0.32200230 |
| 137 | MAPK7 | 0.32187059 |
| 138 | DAPK1 | 0.31868954 |
| 139 | DYRK1B | 0.31736138 |
| 140 | NEK2 | 0.31466311 |
| 141 | GRK1 | 0.31122891 |
| 142 | CDK8 | 0.31034574 |
| 143 | PRKCQ | 0.31011368 |
| 144 | RPS6KA2 | 0.30991525 |
| 145 | ERBB3 | 0.29529733 |
| 146 | TGFBR1 | 0.29276737 |
| 147 | MKNK1 | 0.28012852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.11034988 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55488545 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52393206 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48010690 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34593292 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33723756 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.20895978 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18964963 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18603596 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.16271280 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07386435 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.02014315 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99893984 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.99626685 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.94821252 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93736544 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.89055856 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82978590 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80669648 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80292603 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.79347715 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.71281849 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71112385 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68857547 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67605837 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.55480787 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.51952342 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.50500698 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48492068 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.48161112 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47001548 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44229185 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41988842 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.40968434 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37352479 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36962149 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.32940865 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30078497 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.29078586 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28778832 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.27491918 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.27140069 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26436349 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26033562 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24768777 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.24448936 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21293805 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16346084 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12519875 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.12190415 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11011125 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09750464 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.05511150 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 1.05495500 |
| 55 | Morphine addiction_Homo sapiens_hsa05032 | 1.03136745 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99882775 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99268737 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98458448 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.98146026 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97754176 |
| 61 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96648287 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96512904 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93545600 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.92636935 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91835893 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88234142 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85440313 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84911655 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83755729 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79694882 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77223759 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76295731 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75227063 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75097027 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74723863 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74606012 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.73892487 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.72795578 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72737036 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.71888219 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71874524 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71322909 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.70931114 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70535025 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69498841 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66887076 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65497571 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65316359 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65146176 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64044021 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63556976 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62617008 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62482408 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60045440 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54982902 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54903309 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54780052 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53613381 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53448663 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53305272 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50723556 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50501927 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49531979 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49477378 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49208649 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49140709 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47118634 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43729502 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.43605336 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43203115 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42777954 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42317880 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41754993 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39630532 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38987719 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38371856 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38085704 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36618620 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36597704 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36095779 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36046266 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35804392 |
| 123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35478318 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.34707374 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33912934 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33784387 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31683258 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31489191 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30982325 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.30677914 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28865186 |
| 132 | Spliceosome_Homo sapiens_hsa03040 | 0.27464565 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27334263 |
| 134 | Cell cycle_Homo sapiens_hsa04110 | 0.27273955 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26890435 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26750275 |

